Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Mark Eckardt

Concepts (220)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Sarcoma
10
2026
209
1.880
Why?
Liposarcoma
4
2023
31
1.200
Why?
Soft Tissue Neoplasms
4
2025
133
1.100
Why?
Psoriasis
2
2024
110
0.900
Why?
Mindfulness
2
2024
134
0.830
Why?
Doxorubicin
9
2018
416
0.750
Why?
Retroperitoneal Neoplasms
1
2022
28
0.740
Why?
Carbon-Sulfur Lyases
6
2018
14
0.710
Why?
Xenograft Model Antitumor Assays
9
2018
930
0.630
Why?
Referral and Consultation
1
2025
881
0.570
Why?
Salmonella typhimurium
5
2018
194
0.500
Why?
Antimetabolites, Antineoplastic
2
2018
108
0.390
Why?
Radiodermatitis
1
2013
11
0.380
Why?
Deoxycytidine
2
2018
219
0.370
Why?
Compartment Syndromes
1
2013
36
0.370
Why?
Sarcoma, Ewing
3
2018
103
0.350
Why?
Philadelphia Chromosome
1
2011
18
0.350
Why?
Chromosomes, Human, Pair 19
1
2011
28
0.350
Why?
Blast Crisis
1
2011
34
0.350
Why?
Hemangioendothelioma, Epithelioid
1
2011
7
0.340
Why?
Chromosomes, Human, Pair 1
1
2011
82
0.340
Why?
Drug Resistance, Neoplasm
6
2018
893
0.340
Why?
Thiazoles
1
2011
139
0.330
Why?
Mice, Nude
11
2018
668
0.320
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2011
128
0.320
Why?
Pyrimidines
3
2018
532
0.320
Why?
Nerve Sheath Neoplasms
2
2019
14
0.300
Why?
Recombinant Proteins
5
2018
1361
0.300
Why?
Image-Guided Biopsy
2
2019
41
0.250
Why?
Melanoma
3
2018
765
0.250
Why?
Bone Matrix
2
2018
6
0.250
Why?
Sphincterotomy, Transduodenal
1
2025
2
0.220
Why?
Neoplasm Recurrence, Local
4
2022
1160
0.220
Why?
Piperazines
3
2018
368
0.220
Why?
Extremities
1
2026
142
0.220
Why?
Ampulla of Vater
1
2025
40
0.220
Why?
Cyclin-Dependent Kinase 4
2
2016
52
0.210
Why?
Cyclin-Dependent Kinase 6
2
2016
49
0.210
Why?
Lumbar Vertebrae
2
2018
260
0.210
Why?
Gastric Bypass
1
2025
115
0.200
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2019
1998
0.200
Why?
Pyridines
3
2018
610
0.190
Why?
Spinal Fusion
2
2018
265
0.190
Why?
Lipoma
1
2023
17
0.190
Why?
Humans
35
2026
146342
0.190
Why?
Retrospective Studies
10
2026
17438
0.190
Why?
Bone Marrow Transplantation
2
2015
301
0.180
Why?
Robotic Surgical Procedures
1
2025
210
0.180
Why?
Microsatellite Instability
1
2022
57
0.170
Why?
Bone Neoplasms
2
2016
272
0.170
Why?
Antineoplastic Agents
3
2018
2219
0.170
Why?
Salmonella Infections
2
2018
59
0.160
Why?
Positron Emission Tomography Computed Tomography
1
2021
122
0.160
Why?
Gastrointestinal Stromal Tumors
1
2021
41
0.160
Why?
Adolescent
8
2025
22557
0.160
Why?
Biopsy, Large-Core Needle
1
2019
15
0.150
Why?
Self Report
1
2024
870
0.150
Why?
Colorectal Neoplasms
2
2022
874
0.150
Why?
Neoadjuvant Therapy
2
2020
475
0.150
Why?
Cisplatin
2
2018
347
0.150
Why?
Proto-Oncogene Proteins B-raf
2
2018
231
0.150
Why?
Lipopolysaccharides
1
2022
861
0.140
Why?
Fibrosarcoma
1
2018
22
0.140
Why?
Prognosis
6
2026
4351
0.140
Why?
Aged
11
2026
26432
0.140
Why?
Bone Demineralization Technique
1
2018
1
0.140
Why?
Receptor, Platelet-Derived Growth Factor alpha
1
2018
54
0.130
Why?
Furans
1
2017
26
0.130
Why?
Pseudomonas putida
1
2018
44
0.130
Why?
Osteosarcoma
1
2018
100
0.130
Why?
Ketones
1
2017
51
0.120
Why?
Female
17
2026
79499
0.120
Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2016
15
0.120
Why?
RNA-Binding Protein FUS
1
2016
15
0.120
Why?
Combined Modality Therapy
3
2018
1271
0.120
Why?
Cell Tracking
1
2016
19
0.120
Why?
Receptor, IGF Type 1
1
2016
64
0.120
Why?
Tumor Microenvironment
1
2021
747
0.120
Why?
Bone Marrow
1
2018
310
0.120
Why?
Middle Aged
10
2026
36619
0.120
Why?
Male
16
2026
73396
0.110
Why?
Immunotherapy
1
2021
671
0.110
Why?
Neoplasms, Experimental
1
2016
163
0.110
Why?
Luminescent Proteins
1
2016
188
0.110
Why?
Bone Transplantation
1
2015
91
0.110
Why?
Oncogene Proteins, Fusion
1
2016
213
0.100
Why?
Postoperative Complications
2
2025
3034
0.100
Why?
Depression
1
2024
1575
0.100
Why?
Body Weight
4
2018
968
0.100
Why?
Precision Medicine
1
2018
462
0.100
Why?
Aurora Kinase A
1
2013
57
0.100
Why?
Molecular Targeted Therapy
1
2016
447
0.100
Why?
Sarcoma, Synovial
1
2013
20
0.100
Why?
Random Allocation
3
2018
366
0.100
Why?
Prospective Studies
2
2022
8123
0.090
Why?
Young Adult
4
2025
14330
0.090
Why?
Phthalazines
1
2013
64
0.090
Why?
Musculoskeletal Diseases
1
2014
95
0.090
Why?
Tumor Burden
3
2018
326
0.090
Why?
Adult
8
2026
41087
0.090
Why?
Curettage
1
2012
8
0.090
Why?
Giant Cell Tumor of Bone
1
2012
8
0.090
Why?
T-Lymphocytes
1
2021
2012
0.090
Why?
Animals
13
2018
38107
0.090
Why?
Dasatinib
1
2011
58
0.080
Why?
Surveys and Questionnaires
1
2024
6073
0.080
Why?
Fatal Outcome
1
2011
302
0.080
Why?
Tibia
1
2012
177
0.080
Why?
Mice
8
2018
18297
0.080
Why?
Survival Analysis
3
2019
1378
0.070
Why?
Databases, Factual
3
2020
1493
0.070
Why?
Tumor Suppressor Protein p53
1
2013
530
0.070
Why?
Mutation
2
2018
4093
0.070
Why?
Fatty Liver
1
2011
252
0.070
Why?
Indazoles
2
2018
86
0.070
Why?
Lung Neoplasms
2
2018
2675
0.060
Why?
Green Fluorescent Proteins
2
2018
408
0.060
Why?
France
1
2026
40
0.060
Why?
Italy
1
2026
118
0.060
Why?
Tumor Cells, Cultured
2
2018
882
0.060
Why?
Administration, Oral
2
2018
872
0.060
Why?
Liver Neoplasms
1
2011
776
0.050
Why?
Constriction, Pathologic
1
2025
240
0.050
Why?
Sulfonamides
2
2018
594
0.050
Why?
Bayes Theorem
1
2026
426
0.050
Why?
Cell Proliferation
3
2018
2502
0.050
Why?
Mitotic Index
1
2023
24
0.050
Why?
Disease Models, Animal
3
2018
4580
0.050
Why?
Drug Screening Assays, Antitumor
2
2013
194
0.050
Why?
Neoplasms
1
2018
2954
0.040
Why?
Treatment Outcome
4
2018
11821
0.040
Why?
Mitosis
1
2023
195
0.040
Why?
DNA Mismatch Repair
1
2022
54
0.040
Why?
Neoplasm Staging
2
2019
1488
0.040
Why?
Imatinib Mesylate
1
2021
77
0.040
Why?
Radiopharmaceuticals
1
2021
210
0.040
Why?
Fluorodeoxyglucose F18
1
2021
164
0.040
Why?
Cell Cycle
2
2013
595
0.040
Why?
Germany
1
2020
139
0.040
Why?
Neurofibroma
1
2019
8
0.040
Why?
Positron-Emission Tomography
1
2021
343
0.040
Why?
Neurilemmoma
1
2019
26
0.040
Why?
Lymphocytes, Tumor-Infiltrating
1
2021
156
0.040
Why?
Risk Assessment
2
2019
3712
0.040
Why?
Hospitals, High-Volume
1
2019
51
0.040
Why?
Age Factors
2
2018
3347
0.040
Why?
Chemotherapy, Adjuvant
1
2020
429
0.040
Why?
Magnetic Resonance Imaging
1
2011
3926
0.030
Why?
Cohort Studies
2
2019
6077
0.030
Why?
S Phase Cell Cycle Checkpoints
1
2018
4
0.030
Why?
G2 Phase Cell Cycle Checkpoints
1
2018
43
0.030
Why?
Empathy
1
2020
184
0.030
Why?
Gene Amplification
1
2018
116
0.030
Why?
Suction
1
2018
31
0.030
Why?
Transplantation, Heterologous
1
2018
165
0.030
Why?
Injections, Intraperitoneal
1
2017
115
0.030
Why?
Taxoids
1
2018
115
0.030
Why?
Point Mutation
1
2018
232
0.030
Why?
Heterografts
1
2018
143
0.030
Why?
Neoplasm Invasiveness
1
2019
504
0.030
Why?
California
1
2019
475
0.030
Why?
Disease-Free Survival
1
2019
778
0.030
Why?
Administration, Intravenous
1
2017
172
0.030
Why?
Artificial Intelligence
1
2022
389
0.030
Why?
Kaplan-Meier Estimate
1
2019
970
0.030
Why?
Early Detection of Cancer
1
2022
506
0.030
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2016
74
0.030
Why?
Orthopedic Procedures
1
2019
260
0.030
Why?
Academic Medical Centers
1
2019
561
0.030
Why?
Pyrazines
1
2016
94
0.030
Why?
Proportional Hazards Models
1
2019
1331
0.030
Why?
Ilium
1
2015
31
0.030
Why?
Drug Administration Schedule
1
2017
790
0.030
Why?
Cell Line, Tumor
2
2013
3545
0.030
Why?
Multivariate Analysis
1
2019
1543
0.030
Why?
Diagnosis, Differential
1
2019
1503
0.030
Why?
Drug Therapy, Combination
1
2018
1036
0.030
Why?
Imidazoles
1
2016
245
0.030
Why?
Drug Delivery Systems
1
2018
377
0.030
Why?
Apoptosis
2
2013
2439
0.030
Why?
Reoperation
1
2018
645
0.030
Why?
Sensitivity and Specificity
1
2019
1998
0.030
Why?
Allografts
1
2015
151
0.030
Why?
Transplantation, Autologous
1
2015
306
0.030
Why?
Transplantation, Homologous
1
2015
416
0.030
Why?
Aurora Kinase C
1
2013
2
0.030
Why?
Aurora Kinase B
1
2013
10
0.030
Why?
Biopsy, Needle
1
2014
183
0.020
Why?
Retinoblastoma Protein
1
2013
63
0.020
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2013
104
0.020
Why?
DNA Copy Number Variations
1
2013
192
0.020
Why?
DNA Mutational Analysis
1
2013
410
0.020
Why?
Femoral Neoplasms
1
2012
10
0.020
Why?
Radius
1
2012
53
0.020
Why?
Organoplatinum Compounds
1
2011
65
0.020
Why?
CD8-Positive T-Lymphocytes
1
2018
931
0.020
Why?
Liver Function Tests
1
2011
103
0.020
Why?
Mice, Transgenic
1
2016
2134
0.020
Why?
Aged, 80 and over
2
2015
8391
0.020
Why?
Carcinoma, Renal Cell
1
2013
231
0.020
Why?
Logistic Models
1
2015
2126
0.020
Why?
Biomarkers
1
2021
4340
0.020
Why?
Dose-Response Relationship, Drug
1
2013
2022
0.020
Why?
Phosphorylation
1
2013
1724
0.020
Why?
Kidney Neoplasms
1
2013
419
0.020
Why?
Gene Expression
1
2013
1463
0.020
Why?
Quality of Life
1
2020
3200
0.020
Why?
Gene Expression Regulation, Neoplastic
1
2013
1432
0.020
Why?
Protein Kinase Inhibitors
1
2013
983
0.020
Why?
Biomarkers, Tumor
1
2013
1339
0.010
Why?
Sex Factors
1
2011
2107
0.010
Why?
Follow-Up Studies
1
2014
5439
0.010
Why?
Child
2
2014
22693
0.010
Why?
Liver
1
2011
1864
0.010
Why?
Body Mass Index
1
2011
2458
0.010
Why?
United States
1
2020
16136
0.010
Why?
Breast Neoplasms
1
2013
2418
0.010
Why?
Infant
1
2014
10114
0.010
Why?
Child, Preschool
1
2014
11913
0.010
Why?
Risk Factors
1
2011
10921
0.010
Why?
Eckardt's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)